Hoare S.R. “ . .The structure and function of the glucagon-like peptide-1 receptor and its ligands. British Journal of Pharmacology, 146(2005) : 291-301.
Chen C.M. .2017 .Exendin-4 antagonizes the metabolic action of acylated ghrelinergic signaling in the hypothalamic paraventricular nucleus. PLoS One, 12(11) : e0188722.
Eng J. .1992 .Isolation and characterization of exendin-4, a new 39-residue peptide, an agonist for the glucagon-like peptide-1 (GLP-1) receptor, from the venom of the Gila monster (Heloderma suspectum). ” Journal of Biological Chemistry, 267(26) : 18884-18887.
Zhao J.S. .2016 .Truncated glucagon-like peptide-1 and exendin-4 α-conotoxin pl14a peptide chimeras maintain potency and α-helicity and reveal interactions vital for cAMP signaling in vitro. ” Journal of Biological Chemistry, 291(35) : 18321-18332.
Leitgeb Paradiž,E. Paradiž . .Exendin-4 affects calcium signalling predominantly during activation and activity of beta cell networks in acute mouse pancreas tissue slices. ” BMC Biology, 22(2024) : 16.
Shu Z. . .Exendin-4 gene modification and microscaffold encapsulation promote self-persistence and antidiabetic activity of MSCs. Stem Cell Research and Therapy, 15(2024) : 169.
Wang X. . .Exendin-4 antagonizes Aβ1-42 induced attenuation of spatial learning and memory ability. ” Experimental and Therapeutic Medicine, 12(2016) : 2885-2892.
Holscher C. .2022 .The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: an in-depth review. ” Frontiers in Neuroscience, 16 : 970925.
Wang J. . .Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes. ” Journal of Investigative Medicine, 63(2015) : 564-568.
Szafraniec M. . .Beneficial influence of exendin-4 on specific organs and mechanisms favourable for the elderly with concomitant obstructive lung diseases. ” Diseases, 12(2022) : 1090.
Cas Dei,A. Dei . .“Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-ofconcept clinical trial. ” Journal of Endocrinological Investigation, 47(2024) : 629-638.
Zhang Y. .2021 .Association between exenatide use and incidence of Alzheimer's disease.” Alzheimer's and Dementia. , 17(10) : 1601-1609.